Reported sales nil
Net loss of Rubra Medicaments reported to Rs 0.01 crore in the quarter ended June 2020 as against net profit of Rs 0.01 crore during the previous quarter ended June 2019. There were no Sales reported in the quarter ended June 2020 as against Rs 0.09 crore during the previous quarter ended June 2019. ParticularsQuarter EndedJun. 2020Jun. 2019% Var.Sales00.09 -100 OPM %011.11 -PBDT-0.010.01 PL PBT-0.010.01 PL NP-0.010.01 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content